Instil Bio Inc reports results for the quarter ended June 30 - Earnings Summary

• Instil Bio Inc TIL.OQ reported a quarterly adjusted loss of $3.24​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $-2.29. The mean expectation of four analysts for the quarter was for a loss of $2.50 per share. Wall Street expected results to range from $-3.83 to $-1.72 per share.

• Reported revenue was zero​; analysts expected zero.

• Instil Bio Inc's reported EPS for the quarter was a loss of $3.24​.

• The company reported a quarterly loss of $21.4 million.

• Instil Bio Inc shares had risen by 28.8% this quarter and gained 40.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 13.9% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Instil Bio Inc is $125.00, about 78.5% above its last closing price of $26.83

This summary was machine generated from LSEG data August 13 at 10:22 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)